Everolimus (Afinitor) approved for use in Scotland for Net Cancer Patients

The Scottish Medicines Consortium decision regarding Everolimus (Afinitor) was announced this afternoon. The relevant Detailed Advice Document can be found here.

Thank you to all who took part in the survey and the focus group. You can read our submission here.